Deoxyglucose uptake by a head and neck squamous carcinoma: Influence of changes in proliferative fraction

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 1, 2000, Pages 219-223

  Smith, T A D ^a   Titley, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Deoxy D glucose; In vitro; Proliferation; Tumor

Indexed keywords

DEOXYGLUCOSE; LACTIC ACID; TRITIUM;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CELL COUNT; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LACTIC ACID; RADIOBIOLOGY; RADIOPHARMACEUTICALS; S PHASE; TUMOR CELLS, CULTURED;

EID: 0034177230     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00411-9     Document Type: Article

References (27)

1. Resser J.R., Carbone D.P. Immunotherapy of head and neck cancer. Curr Opin Oncol. 10:1998;226-232.
2. Welters M.J., Fichtinger-Schepman A.M., Baan R.A., et al. Relationship between the parameter cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines. Int J Cancer. 71:1997;410-415.
3. Adelstein D.J. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol. 10:1998;213-218.
4. Wong W.L., Chevretton E.B., Hussain K., et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol. 22:1997;209-214.
5. Minn H., Paul R., Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18fluorodeoxyglucose. J Nucl Med. 29:1988;1521-1525.
6. Berlangieri S.U., Brizel D.M., Scher R.L., et al. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck. 16:1994;340-346.
7. Lowe V.J., Dunphy F.R., Varvares M., et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck. 19:1997;666-674.
8. Haberkorn U., Strauss L.G., Dimitrakopoulou A., et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med. 34:1993;12-17.
9. Gan Y., Wientjes M.G., Schuller D.E., Au J.L. Pharmacokinetics of taxol in human head and neck tumour. Cancer Res. 56:1996;2086-2093.
10. Grandis J.R., Chakrabarty A., Zeng Q., Melhim M.F., Tweardy D.J. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal cells. J Cell Biochem. 69:1998;55-62.
11. Fodge D.W., Rubin H. Glucose utilization, pH reduction and density dependent inhibition in cultures of chick embryo fibroblasts. J Cell Physiol. 85:1974;635-642.
12. Smith T.A.D., Titley J.C., McCready V.R. Proliferation is associated with 2-Deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol. 25:1998;281-285.
13. Minn H., Clavo A.C., Grenman R., Wahl R.L. In-vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med. 36:1995;252-258.
14. Waki A., Fujibayashi Y., Yonekura Y., Sadato N., Ishii Y., Yokoyama A. Reassessment of FDG uptake in tumor cells High FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production . Nucl Med Biol. 24:1997;665-670.
15. Artemov D., Bhujwalla Z.M., Pilatus U., Glickson J.D. Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C spectroscopy. NMR Biomedicine. 11:1998;395-404.
16. Hugo F., Mazurek S., Zander U., Eigenbrodt E. In vitro effect of extracellular AMP on MCF-7 breast cancer cells Inhibition of glycolysis and cell proliferation . J Cell Physiol. 153:1992;539-549.
17. Street J.C., Alfieri A.A., Koutcher J.A. Quantification of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro. Cancer Res. 57:1997;3956-3962.
18. Wieser R.J., Faust D., Dietrich C., Oesch F. p16INK4 mediates contact-inhibition of growth. Oncogene. 18:1999;277-281.
19. Moreton K., Turner R., Blake N., Paton A., Groome N., Rumsby M. Protein expression of the alpha, gamma, delta and epsilon subspecies of protein kinase C changes as C6 glioma cells become contact inhibited and quiescent in the presence of serum. FEBS Lett. 372:1995;33-38.
20. Awazu S., Nakata K., Hida D., Sakamoto T., Nagat K., Ishii N., Kanematsu T. Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells. Biochem Biophys Res Commun. 252:1998;269-273.
21. Dietrich C., Wallenfang K., Oesch F., Wieser R. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene. 15:1997;2743-2747.
22. Berridge M.V., Tan A.S. Interleukin-3 facilitates glucose transport in a myeloid cell line by regulating the affinity of the glucose transporter for glucose Involvement of protein phosphorylation in transporter activation . Biochem J. 305:1995;843-851.
23. Pallen C.J., Tong P.H. Elevation of membrane tyrosine phosphatase activity in density-dependent growth-arrested fibroblasts. Proc Natl Acad Sci. 88:1991;6996-7000.
24. Luc C.K., Keng P.C., Sutherland R.M. Regrowth and radiation sensitivity of quiescent cells isolated from EMT6/Ro-fed plateau monolayers. Cancer Res. 45:1985;1020.
25. Higashi K., Clavo A.C., Wahl R.L. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med. 34:1993;773-779.
26. Bristow R.G., Benchimol S., Hill R.P. The p53 gene as a modifier of intrinsic radiosensitivity Implications for radiotherapy . Radiother Oncol. 40:1996;197-223.
27. Yen A., Varvayanis S. RB tumor suppressor gene expression responds to DNA synthesis inhibitors. In Vitro Cell Dev Biol. 28:1992;669-672.